Navigation Links
ASA in Medical Technology

New Research Confirms the Benefit of Extended-Release Dipyridamole Plus ASA for Preventing Recurrent Stroke in Low- and High-Risk Patients

Aggrenox® (Asasantin® Retard) considered by many as first-line in secondary stroke prevention INGELHEIM, Germany, 31 May 2007 - New data presented today at the 16th European Stroke Conference in Glasgow confirm that therapy with dipyridamole plus ASA (extended-release dipyridamole plus...

AstraZeneca Submits NDA for Low Dose Aspirin/Esomeprazole Combination Product

...with a three-fold higher risk of major CV events,(4A) which can occur within just 1-2 weeks of discontinuation.(4B) Up to 1 in 3 patients on low-dose asa may develop upper GI symptoms.(5A,6A) AstraZeneca conducted two studies to evaluate the safety and efficacy of NEXIUM in reducing the risk of gas...

Algeta Completes Comprehensive Phase II Clinical Program With Alpharadin for Treating Bone Metastases in Patients With Advanced Prostate Cancer

...haradin to Treat Bone Metastases in Major Cancer Indications Algeta asa (OSE: ALGETA), the cancer therapeutics company, announces that with the res...ick on the ALSYPMCA link in the menu bar. About Algeta Algeta asa is a cancer therapeutics company built on world-leading, proprietary techno...

Diagenic Announces Launch of First Breast Cancer Gene-Expression Blood Test

...rate Test's Potential for Rapid Uptake OSLO and FOSTER CITY, California, November 10 /PRNewswire-FirstCall/ -- DiaGenic asa (OSL: DIAG) and Applied Biosystems Inc. (NYSE: ABI ) today announced the launch of BCtect(TM), a blood-based test for early detection of breast cance...

Thermogard XP(TM) Studies to Be Presented at American Society of Anesthesiologists Annual Meeting

... after the surgery. Therefore, modulating temperature becomes a very important tool in the physician's armamentarium. The cases being presented at the asa underscore the utility of temperature management for these situations." Various factors contribute to hypothermia during surgery, including the type...

Algeta Reports Positive Headline Phase II Data on Pain Palliation With Alpharadin

...urvival of Patients With Hormone Refractory Prostate Cancer (HRPC) Algeta asa (OSE: ALGETA), the Norwegian cancer therapeutics company, today announced t... Research and the Royal Marsden Hospital in the UK. About Algeta Algeta asa is a Norwegian cancer therapeutics company built on world-leading, propriet...

Michael J. Fox Foundation Funds $1.1 Million for Cutting-Edge Approaches to Parkinson's Disease Under Rapid Response Innovation Awards 2008

... provided the head of their lab serves as administrative PI. Among the potentially high-impact Rapid Response projects funded so far this year: -- asa Abeliovich, MD, PhD, of Columbia University is working to determine whether a gene silencing technique using microRNAs -- short, noncoding molecules o...

Data Presented at Annual Meeting of Japanese Society of Interventional Cardiology Demonstrate OrbusNeich's Genous(TM) Bio-engineered R Stent(TM) Has Better Outcomes When Compared to Drug-Eluting Stents

...patients, with an average antiplatelet therapy duration of 12.5 days. After NCS, thienopyridine administration was not restarted and 100 mg per day of asa was the only cardiac antiplatelet therapy at discharge. MACE, including in-hospital cardiac death, MI, stent thrombosis, surgical bleeding complicatio...

Shire Enhances its Orphan Drug Pipeline With the Acquisition of a New Clinical Candidate for Metachromatic Leukodystrophy

...reversible neurological damage. MLD is caused by a deficiency in the enzyme asa which causes an excess concentration of sulphatide in cells and an ensuing ...tely 2,000 MLD patients in developed world markets(1). The newly acquired asa product, currently known as METAZYM(TM), has completed a Phase Ib clinical ...

Dr. Harriet Robinson Joins GeoVax Team as V.P. of R & D to Accelerate AIDS Vaccine Trials Program

...under of GeoVax Labs, Inc. She served as Chief of Microbiology and Immunology at Emory University's Yerkes National Primate Research Center and was an asa Griggs Candler Professor of Microbiology and Immunology at the Emory University School of Medicine. Dr. Robinson is a pioneer in DNA vaccines and on...

Plavix(R) Indications Expanded in Japan to Include Patients with Acute Coronary Syndrome for Whom Percutaneous Coronary Intervention Is Being Planned

...e Japan, Plavix(R) has shown favourable tolerability profile as compared to asa and an acceptable increase in major bleedings when used in combination with asa (no statistical difference when only PCIs are considered). In Japan, Plavi...

Sugammadex Trials Demonstrate Rapid Recovery from Profound Neuromuscular Blockade During General Anesthesia

...review by the EMEA was announced on July 20, 2007. The anticipated submissions for the U.S. and Japan are on schedule for later this year. During this asa annual meeting results from four additional Phase III trials were presented. About Organon Organon creates, manufactures and markets innovative pres...

MGI Pharma Announces Positive Results from a Pivotal Phase 3 Study of Aquavan Injection in Patients Undergoing Bronchoscopy

...rate was 86.7% compared to 25.5% among patients treated with an initial bolus control dose of 2.0 mg/kg of Aquavan (p less than 0.001). Based upon the asa Physical Status Classification System, 31% of patients in this study were classified as P1 (having no known systemic disease), 65% were classified as ...

Viral Enzyme Recruited in Fight Against Ear Infection

...Fischetti. "This might truly be a case in which an ounce of prevention would be worth a pound of cure." Other St. Jude authors of this paper include asa Karlstrom and Amy R. Iverson (St. Jude). This work was supported in part by the United States Public Health Service and ALSAC. St. Jude Children's...

Algeta to Present Phase II Clinical Study Data for Alpharadin in Prostate Cancer at ASCO

... OSLO, Norway, 30 May 2007 - Algeta asa (OSE: ALGETA), the Norwegian cancer therapeutics company, announces that Pr...rk.swallow@citigatedr.co.uk Citigate Dewe Rogerson About Algeta Algeta asa (www.algeta.com ) is a No...

Algeta Demonstrates Targeted Cancer-killing Potential of Novel Alpha Particle Linked Antibodies in Leading Medical Journal Blood

...an 90Y-tiuxetan-ibritumomab (Zevalin) OSLO, Norway, 14 June 2007 - Algeta asa (OSE: ALGETA), the Norwegian cancer therapeutics company, announces that a ...rk.swallow@citigatedr.co.uk Citigate Dewe Rogerson About Algeta Algeta asa (www.algeta.com ) is a No...
Other Tags
(Date:7/21/2015)... , July 21, 2015 Today, ZTE ... Already received as well as expected revenues in 2015 that relate ... FPC,s communicated revenue guidance of approximately 2,200 MSEK for 2015. ... is a leading smartphone manufacturer in China ... FPC1 02 5 for Axon , ...
(Date:7/13/2015)... 13, 2015 NXT-ID, Inc. (NASDAQ: NXTD ... company focused on the growing mobile commerce market, ... 62/188684 for BEHAVIORAL-DIRECTED AUTHENTIATION METHOD AND ... and secure method to make payments.  With this ... introduced with its groundbreaking voice-direct payment patent application, ...
(Date:7/8/2015)... , July 8, 2015 Summary Pancreatic ... the fourth most fatal, with a mortality rate of ... prognosis of pancreatic cancer patients has highlighted a significant ... is not being met by the current market. ... of products with varying molecule types and mechanisms of ...
Breaking Biology News(10 mins):FPC's Touch Fingerprint Sensor FPC1025 in ZTE's Smartphone Axon 2NXT-ID Patents Behavior-Directed Payments 2NXT-ID Patents Behavior-Directed Payments 3NXT-ID Patents Behavior-Directed Payments 4Frontier Pharma: Pancreatic Cancer - Identifying and Commercializing First-in-Class Innovation 2Frontier Pharma: Pancreatic Cancer - Identifying and Commercializing First-in-Class Innovation 3
(Date:7/31/2015)... ... July 31, 2015 , ... ... and the growing number of individuals who remain undiagnosed, treatment options for patients ... shy away from traditional CPAP therapy due to its overall lack of comfort ...
(Date:7/30/2015)... ... July 30, 2015 , ... Dale Sky Jones, Executive Chancellor of ... at the International Cannabis Professionals Expo held at the Caribe Royal All Suites Hotel ... Cannabis Professionals Expo is the largest medical cannabis expo in the country and ...
(Date:7/30/2015)... (PRWEB) , ... July 31, 2015 , ... The Venetian on Grace Bay in the ... Guests who stay at the Venetian will save 40% on their stay while enjoying some ... always quiet in the Turks & Caicos, providing a chance to reconnect with loved ones ...
(Date:7/30/2015)... Ferry, New York (PRWEB) , ... July 31, 2015 , ... ... Barack Obama’s call to action by asking community members to contribute to the College’s ... on, “Helping more of our young people stay on track. Providing the support they ...
(Date:7/30/2015)... ... July 30, 2015 , ... As more hospitals across ... of recruiting patients becomes a serious challenge. Because of growing competition, it is ... within the local community. , The team at Wound Care Advantage ...
Breaking Medicine News(10 mins):Health News:Oravan Sleep Apnea Device Gains Traction in Sleep Industry 2Health News:Finally…First Ever Professional Training Event for Doctors and Nurses Wanting to Offer Medical Marijuana Recommendations to Patients 2Health News:Finally…First Ever Professional Training Event for Doctors and Nurses Wanting to Offer Medical Marijuana Recommendations to Patients 3Health News:Finally…First Ever Professional Training Event for Doctors and Nurses Wanting to Offer Medical Marijuana Recommendations to Patients 4Health News:Finally…First Ever Professional Training Event for Doctors and Nurses Wanting to Offer Medical Marijuana Recommendations to Patients 5Health News:The Venetian on Grace Bay in Turks & Caicos Islands Offers 40% Savings This Fall. 2Health News:Mercy College a “My Brother’s Keeper” Community 2Health News:Mercy College a “My Brother’s Keeper” Community 3Health News:WCA Offers Shockwave; The Marketing Module for Hospital Wound Care Programs 2Health News:WCA Offers Shockwave; The Marketing Module for Hospital Wound Care Programs 3Health News:WCA Offers Shockwave; The Marketing Module for Hospital Wound Care Programs 4
Other Contents